Angioplasty versus thrombolysis for acute myocardial infarction

References

• Pell S, Fayerweather WE. Trends in the incidence of myocardial infarction and in associated mortality and morbidity in a large employed population, 1957–1983. N Engl J Med 1985; 312(16): 1005–11
   PubMed Web of Science ®Google Scholar
• Gillum RF, Folsom A, Luepker RV, et al. Sudden death and acute myocardial infarction in a metropolitan area, 1970–1980: The Minnesota Heart Survey. N Engl J Med 1983; 309(22): 1353–8
   PubMed Web of Science ®Google Scholar
• Pryor DB, Harrell FE Jr, Lee KL, et al. An improving prognosis over time in medically treated patients with coronary artery disease. Am J Cardiol 1983; 52(5): 444–8
   PubMed Web of Science ®Google Scholar
• The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309(6): 331–6
   PubMed Web of Science ®Google Scholar
• Chesebro JH, Knatternd G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76(1): 142–54
   PubMed Web of Science ®Google Scholar
• Gruppo Italiano per lo Studio della Sopravvivenza nell'Infetto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990; 336: 65–71
   PubMed Web of Science ®Google Scholar
• AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo- controlled clinical trial. Lancet 1988; 1 (8585): 545–9
   PubMed Web of Science ®Google Scholar
• ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2(8607): 349–60
   PubMed Web of Science ®Google Scholar
• ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992; 339(8796): 753–70
   PubMed Web of Science ®Google Scholar
• Williams DO, Holubkov AL, Detre KM, et al. Impact of pretreatment by thrombolytic therapy upon outcome of emergent direct coronary angioplasty for patients with acute myocardial infarction. (Abstr) J Am Coll Cardiol 1991; 17(2): 337A
   Google Scholar
• Grines CL, Meany TB, Weintraub R, et al. Streptokinase Angioplasty Myocardial Infarction trial: early and late results. (Abstr) J Am Coll Cardiol 1991; 17(2): 336A
   Google Scholar
• Kahn JK, O'Keefe JH Jr, Rutherford BD, et al. Timing and mechanism of inhospital and late death after primary coronary angioplasty during acute myocardial infarction. Am J Cardiol 1990; 66(15): 1045–8
   PubMed Web of Science ®Google Scholar
• Beauchamp GD, Vacek JL, Robuck W. Management comparison for acute myocardial infarction: direct angioplasty versus sequential thrombolysis-angioplasty. Am Heart J 1990; 120(2): 237–42
   PubMed Web of Science ®Google Scholar
• Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial in farction. N Engl J Med 1993; 328(10): 673–9
   PubMed Web of Science ®Google Scholar
• Brodie BR, Weintraub RA, Stuckey TD, et al. Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy. Am J Cardiol 1991; 67(1): 7–12
   PubMed Web of Science ®Google Scholar
• Simoons ML, Arnold AE, Betriu A, et al Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988; 1(8579): 197–203
   PubMed Web of Science ®Google Scholar
• Ellis SG, O'Neill WW, Bates ER, et al. Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. J Am Coll Cardiol 1989; 13(5): 1122–6
   PubMed Web of Science ®Google Scholar
• Olmsted WL, Groden DL, Silverman ME. Prognosis in survivors of acute myocardial infarction occurring at age 70 years or older. An J Cardiol 1987; 60(13): 971–5
   Google Scholar
• Latting CA, Silverman ME. Acute myocardial infarction in hospitalized patients over age 70. Am Heart J 1980; 100(3): 311–8
   PubMed Web of Science ®Google Scholar
• Eckman MH, Wong JB, Salem DN, et al Direct angioplasty for acute myocardial infarction: a review of outcomes in clinical subsets. Ann Intern Med 1992; 117(8): 667–76
   PubMed Web of Science ®Google Scholar
• Holland KF, O'Neill WW, Bates ER, et al. Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age. Am J Cardiol 1989; 63(7): 399–403
   PubMed Web of Science ®Google Scholar
• Lee TC, Laramee LA, Rutherford BD, et al. Emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients 70 years of age and older. Am J Cardiol 1990; 66(7): 663–7
   PubMed Web of Science ®Google Scholar
• Stone GW, Grines CL, VUetstra R, et al. Primary angioplasty is the preferred therapy for women and the elderly with acute myocardial infarction: results of the Primary Angioplasty in Myocardial Infarction (PAMI) trial. (Abstr) J Am Coll Cardiol 1993; 21(2): 330A–789–1
   Google Scholar
• Grines CL, Booth DC, Nissen SE, et al. Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications. Am J Cardiol 1990; 65(20): 1292–6
   PubMed Web of Science ®Google Scholar
• Kahn JK, Rutherford BD, McConahay DR, et al. Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease. J Am Coll Cardiol 1990; 16(5): 1089–96
   PubMed Web of Science ®Google Scholar
• Muller DW, Topol EJ, Ellis SG, et al. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Am Heart J 1991; 121(4 Pt l): 1042–9
   PubMed Web of Science ®Google Scholar
• Muller DW, Topol EJ, George BS, et al. Two-year outcome after angiographically documented myocardial reperfusion for acute coronary occlusion. Am J Cardiol 1990; 66: 796–801
   PubMed Web of Science ®Google Scholar
• Stone GW, Grines CL, Browne KF, et al. Primary angioplasty reduced in-hospital mortality and morbidity in acute anterior myocardial infarction: results of the Primary Angioplasty in Myocardial Infarction (PAMI) trial. (Abstr) J Am Coll Cardiol 1993; 21(2): 331A–789–3
   PubMedGoogle Scholar
• Killip T 3d, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967; 20(4): 457–64
   PubMed Web of Science ®Google Scholar
• Hilborne LH, Leape LL, Kahan JP, et al. Percutaneous transluminal coronary angioplasty: a literature review and ratings of appropriateness and necessity. Santa Monica, Calif: RAND, 1991: 89–90
   Google Scholar
• Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1 (8478): 397–402
   PubMed Web of Science ®Google Scholar
• Handlin LL, Vacek JL, Rosamond TL, et al. Direct angioplasty vs initial thrombolytic therapy for acute myocardial infarction: long term follow-up and changes in practice. (Abstr) Circulation 1992; 86(4) I.1–729
   Google Scholar